Advanced Biomed is trading about 10% up now at $8.76 as the stock rebounds from last week’s sharp swings tied to its withdrawal of a planned $25 million Form S-1 securities offering and related stock purchase agreement.

  • The recovery comes as traders recalibrate risk after the company scrapped its planned financing deal.
  • Shares are also benefiting from a broader upward trend in the biotech sector as overall market sentiment improves.